|
|
|
| Influencing factors of macular degeneration in middle-aged and elderly populations |
| XIAO Qiong, LIU Limei, WU Chenchan, XU Lu
|
| Department of Ophthalmology, Hangzhou First People's Hospital, Hangzhou, Zhejiang 310000, China |
|
|
|
|
Abstract Objective To investigate the factors affecting macular degeneration (MD) in middle-aged and elderly populations, so as to provide the reference for prevention and treatment of MD. Methods People at ages of 50 years and older who were admitted to ophthalmology department of Hangzhou First People's Hospital and received MD screening were selected as the study subjects. General information including age, gender, eye-using habits and family history of MD were collected by questionnaire surveys. MD was diagnosed by ophthalmological examination, and the prevalence of MD in middle-aged and elderly people was analyzed. A multivariable logistic regression model was used to identify the influencing factors of MD. Results A total of 2 832 people were investigated, including 1 527 males (53.92%) and 1 305 females (46.08%), and 1 878 people (66.31%) aged 70 years and older. There were 498 people (17.58%) with good eye-using habits, 1 180 (41.67%) with general eye-using habits and 1 154 (40.75%) with poor eye-using habits. There were 1 817 people with family history of MD (64.16%). Multivariable logistic regression analysis showed that people at ages of 70 years and older (OR=2.815, 95%CI: 1.350-5.871), with poor eye-using habits (OR=2.354, 95%CI: 1.373-4.035), with family history of MD (OR=2.782, 95%CI: 1.138-6.799), with cataract (OR=2.593, 95%CI: 1.157-5.815) and with visual central defect (OR=2.601, 95%CI: 1.252-5.404) had a higher risk of MD. Conclusion Age, eye-using habits, family history of MD, cataract and visual central defect are influencing factors for MD in middle-aged and elderly populations.
|
|
Received: 18 October 2023
Revised: 20 December 2023
Published: 20 March 2024
|
|
|
|
|
|
[1] 李子源,魏红,邵毅.微生物群的变化在老年性黄斑变性中作用的研究进展[J].眼科新进展,2023,43(4):323-326.
[2] 林艳辉,高莉茉,姜文敏.基于GBD数据库中国年龄相关性黄斑变性流行病学负担分析[J].中南大学学报(医学版),2023,48(1):106-113.
[3] 孙子雯,汤垟,陈晨,等.年龄相关性黄斑变性的发病机制与抗氧化治疗[J].国际眼科杂志,2020,20(3):468-471.
[4] 黄厚斌,谢海南.与年龄相关性黄斑变性有关的细胞外沉积:视网膜下疣样沉积和网状假性玻璃膜疣[J].眼科,2022,31(6):413-418.
[5] 汪玖玲,郑燕林.年龄相关性黄斑变性的相关危险因素研究进展[J].临床医学进展,2023,13(3):3651-3656.
[6] 田鑫,张玲君,田飞飞,等.用眼习惯评分和父母近视对初中生近视进展相关参数影响[J].中华生物医学工程杂志,2022,28(2):164-168.
[7] 邵毅,温佳怡,令倩.年龄相关性黄斑变性诊断与治疗规范:2022年英国皇家眼科医学会指南解读[J].眼科新进展,2023,43(2):85-88.
[8] 李铭,魏伟.湿性年龄相关性黄斑变性的治疗进展[J].国际眼科杂志,2015,15(2):251-254.
[9] 李筱荣. “中国老年性黄斑变性临床诊断治疗路径”解读[J].实用老年医学,2014,28(10):877-880.
[10] 陈晨凯,王颖异,曹程,等.年龄相关性黄斑变性的危险因素分析及对疾病动物模型构建的启示[J].中国现代应用药学,2021,38(15):1894-1900.
[11] 李会,刘学勤,傅钰仙,等.湿性年龄相关性黄斑变性患者就医延迟现状及影响因素分析[J].护士进修杂志,2022,37(14):1338-1343.
[12] 王心怡,林君芬,翟羽佳,等.眼部和骨骼肌肉症状与使用不同视频显示终端的相关性研究[J].预防医学,2017,29(3):226-230,235.
[13] 许晶晶,胡运韬.年龄相关性黄斑变性遗传学研究进展[J].中华实验眼科杂志,2020,38(8):715-720.
[14] 张浩,高静,柏丁兮,等.中国人群年龄相关性黄斑变性危险因素的Meta分析[J].国际眼科杂志,2021,21(6):1033-1039.
[15] 王海伟,岳岩坤,陈小丽,等.白内障手术对年龄相关性黄斑变性患者视功能及视觉相关生存质量的影响[J].临床和实验医学杂志,2020,19(5):549-553.
[16] 黎昌江,李小芳,陈方安.对比康柏西普和雷珠单抗治疗新生血管性老年性黄斑变性的效果及VEGF、PDGF-AA因子水平[J].中国老年学杂志,2023,43(9):2124-2126. |
|
|
|
